Elevation Oncology (ELEV) Stock

ELEV Watch

Elevation Oncology

$0.3403

$0.0058 1.73%

1 Min 5 Min 15 Min Hourly Daily Weekly

Assets Gross Profit Revenue Earnings Expenses

Chart Sentiment News Fundamentals About

Tendies

@tendies

2091 Trades 45.6% Winrate 185.6% Avg Gain Avg Gain 5722.1% S&P Beat

Bought ELEV Shares

87d ago • Swung • Bullish

down -20.48% At 0.67, Exited 0.54

I just bought 57,000 shares of ELEV at $0.67 because the company's cash position strongly supports its operations. With just a bit of positive news, t... Read More

Exited 80d ago

0 0

Tendies

@tendies

2091 Trades 45.6% Winrate 185.6% Avg Gain Avg Gain 5722.1% S&P Beat

Bought ELEV Shares

93d ago • Swung • Bullish

up 9.79% At 0.59, Exited 0.65

I believe $ELEV is gearing up for a significant bounce soon. After catching its previous spikes, I'm convinced that the next one is just around the co... Read More

Exited 86d ago

0 0

Tendies

@tendies

2091 Trades 45.6% Winrate 185.6% Avg Gain Avg Gain 5722.1% S&P Beat

Bought ELEV Shares

107d ago • Swung • Bullish

up 9.48% At 0.61, Exited 0.67

I've been looking into Elevation Oncology and I really think they have massive potential with their ADC pipeline. With upcoming data releases in 2025 ... Read More

Exited 100d ago

0 0

Tendies

@tendies

2091 Trades 45.6% Winrate 185.6% Avg Gain Avg Gain 5722.1% S&P Beat

Bought ELEV Shares

124d ago • Swung • Bullish

up 7.77% At 0.66, Exited 0.71

I believe ELEV is poised for significant growth as it's nearing key catalyst events in early 2025, and with hedge funds holding a large position, the ... Read More

Exited 117d ago

0 0

Tendies

@tendies

2091 Trades 45.6% Winrate 185.6% Avg Gain Avg Gain 5722.1% S&P Beat

Bought ELEV Shares

147d ago • Swung • Bullish

down -3.94% At 0.59, Exited 0.57

I'm really bullish on ELEV because of their promising Phase 1 trial results and strong cash runway. With major catalysts coming up and a solid pipelin... Read More

Exited 138d ago

0 0